Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Total Debt (2016 - 2022)

Historic Total Debt for Avadel Pharmaceuticals (AVDL) over the last 14 years, with Q3 2022 value amounting to $136.2 million.

  • Avadel Pharmaceuticals' Total Debt fell 411.93% to $136.2 million in Q3 2022 from the same period last year, while for Sep 2022 it was $136.2 million, marking a year-over-year decrease of 411.93%. This contributed to the annual value of $142.4 million for FY2021, which is 1106.54% up from last year.
  • Latest data reveals that Avadel Pharmaceuticals reported Total Debt of $136.2 million as of Q3 2022, which was down 411.93% from $134.3 million recorded in Q2 2022.
  • In the past 5 years, Avadel Pharmaceuticals' Total Debt registered a high of $142.7 million during Q1 2022, and its lowest value of $1.9 million during Q2 2020.
  • In the last 5 years, Avadel Pharmaceuticals' Total Debt had a median value of $127.2 million in 2019 and averaged $102.0 million.
  • Its Total Debt has fluctuated over the past 5 years, first tumbled by 9210.62% in 2020, then soared by 730721.0% in 2021.
  • Over the past 5 years, Avadel Pharmaceuticals' Total Debt (Quarter) stood at $125.2 million in 2018, then increased by 1.65% to $127.2 million in 2019, then rose by 0.76% to $128.2 million in 2020, then increased by 11.07% to $142.4 million in 2021, then dropped by 4.33% to $136.2 million in 2022.
  • Its last three reported values are $136.2 million in Q3 2022, $134.3 million for Q2 2022, and $142.7 million during Q1 2022.